ANAHER, a $150-billion United States company that makes tools used in developing and testing medicines, on Tuesday agreed to buy Masimo for $9.9 billion, expanding in patient-monitoring devices in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results